NDA 19635, held by B Braun. Sodium Chloride.
As of Nov 13, 2026, NDA 19635 (Sodium Chloride 0.45% In Plastic Container, Sodium Chloride 0.9% In Plastic Container, Sodium Chloride 3% In Plastic Container), held by B Braun, was first approved by FDA on Mar 9, 1988, with 26 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE 0.9% Sodium Chloride Injection USP is indicated as pharmaceutic aid and diluent for the infusion of compatible drug additives. Refer to prescribing information accompanying additive drugs.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 9, 1988 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
| Sodium Chloride 0.45% In Plastic Container450MG/100ML · injectable;injection | Sodium Chloride | RxReference drug |
| Sodium Chloride 0.9% In Plastic Container900MG/100ML · injectable;injection | Sodium Chloride | RxReference drug |
| Sodium Chloride 3% In Plastic Container3GM/100ML · injectable;injection | Sodium Chloride | Rx |
| Sodium Chloride 5% In Plastic Container5GM/100ML · injectable;injection | Sodium Chloride | Rx |
| Sodium Chloride 0.9%90MG/10ML (9MG/ML) · solution;injection | Sodium Chloride | RxReference drug |
| Apr 26, 2016 | Supplement 41Manufacturing · Standard review | Approved | None posted |
| Sep 15, 2015 | Supplement 38Manufacturing · Standard review | Approved | None posted |
| Jul 20, 2015 | Supplement 37Manufacturing · Standard review | Approved | None posted |
| Apr 7, 2015 | Supplement 36Manufacturing · Standard review | Approved | None posted |
| Sep 8, 2014 | Supplement 35Manufacturing · Standard review | Approved | |
| Feb 4, 2004 | Supplement 23Labeling | Approved | None posted |
| Feb 4, 2004 | Supplement 22Labeling | Approved | None posted |
| Jun 13, 2003 | Supplement 21Labeling | Approved | None posted |
| Jul 1, 2002 | Supplement 20Manufacturing · Standard review | Approved | None posted |
| Apr 15, 2002 | Supplement 18Manufacturing · Standard review | Approved | None posted |
| Dec 7, 2000 | Supplement 17Manufacturing · Standard review | Approved | None posted |
| May 15, 2000 | Supplement 16Manufacturing · Standard review | Approved | None posted |
| Aug 21, 1998 | Supplement 15Manufacturing · Standard review | Approved | None posted |
| Jul 21, 1993 | Supplement 12Manufacturing · Standard review | Approved | None posted |
| Jul 7, 1993 | Supplement 14Manufacturing · Standard review | Approved | None posted |
| Apr 26, 1993 | Supplement 13Manufacturing · Standard review | Approved | None posted |
| Dec 29, 1992 | Supplement 11Manufacturing · Standard review | Approved | None posted |
| Aug 29, 1991 | Supplement 9Manufacturing · Standard review | Approved | None posted |
| Sep 18, 1990 | Supplement 8Manufacturing · Standard review | Approved | None posted |
| Apr 13, 1990 | Supplement 7Manufacturing · Standard review | Approved | None posted |
| Nov 21, 1989 | Supplement 4Manufacturing · Standard review | Approved | None posted |
| Jul 26, 1989 | Supplement 6Manufacturing · Standard review | Approved | None posted |
| May 5, 1989 | Supplement 5Manufacturing · Standard review | Approved | None posted |
| Dec 21, 1988 | Supplement 3Manufacturing · Standard review | Approved | None posted |
| Aug 25, 1988 | Supplement 2Manufacturing · Standard review | Approved | None posted |
| Apr 4, 1988 | Supplement 1Labeling | Approved | None posted |
| Mar 9, 1988 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters